These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Molecular mechanism of agonist recognition by the ligand-binding core of the ionotropic glutamate receptor 4. Kasper C; Frydenvang K; Naur P; Gajhede M; Pickering DS; Kastrup JS FEBS Lett; 2008 Dec; 582(29):4089-94. PubMed ID: 19022251 [TBL] [Abstract][Full Text] [Related]
23. Mutant cycle analysis of the active and desensitized states of an AMPA receptor induced by willardiines. Kizelsztein P; Eisenstein M; Strutz N; Hollmann M; Teichberg VI Biochemistry; 2000 Oct; 39(42):12819-27. PubMed ID: 11041846 [TBL] [Abstract][Full Text] [Related]
24. Three-dimensional structure of the ligand-binding core of GluR2 in complex with the agonist (S)-ATPA: implications for receptor subunit selectivity. Lunn ML; Hogner A; Stensbøl TB; Gouaux E; Egebjerg J; Kastrup JS J Med Chem; 2003 Feb; 46(5):872-5. PubMed ID: 12593667 [TBL] [Abstract][Full Text] [Related]
25. Chemical interplay in the mechanism of partial agonist activation in alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Mankiewicz KA; Rambhadran A; Wathen L; Jayaraman V Biochemistry; 2008 Jan; 47(1):398-404. PubMed ID: 18081322 [TBL] [Abstract][Full Text] [Related]
26. Model structures of the N-methyl-D-aspartate receptor subunit NR1 explain the molecular recognition of agonist and antagonist ligands. Moretti L; Pentikäinen OT; Settimo L; Johnson MS J Struct Biol; 2004 Mar; 145(3):205-15. PubMed ID: 14960371 [TBL] [Abstract][Full Text] [Related]
31. A quantum biochemistry investigation of willardiine partial agonism in AMPA receptors. Lima Neto JX; Fulco UL; Albuquerque EL; Corso G; Bezerra EM; Caetano EW; da Costa RF; Freire VN Phys Chem Chem Phys; 2015 May; 17(19):13092-103. PubMed ID: 25915595 [TBL] [Abstract][Full Text] [Related]
32. The inner workings of the AMPA receptors. Madden DR Curr Opin Drug Discov Devel; 2002 Sep; 5(5):741-8. PubMed ID: 12630294 [TBL] [Abstract][Full Text] [Related]
33. Characterization of the 1H-cyclopentapyrimidine-2,4(1H,3H)-dione derivative (S)-CPW399 as a novel, potent, and subtype-selective AMPA receptor full agonist with partial desensitization properties. Campiani G; Morelli E; Nacci V; Fattorusso C; Ramunno A; Novellino E; Greenwood J; Liljefors T; Griffiths R; Sinclair C; Reavy H; Kristensen AS; Pickering DS; Schousboe A; Cagnotto A; Fumagalli E; Mennini T J Med Chem; 2001 Dec; 44(26):4501-4. PubMed ID: 11741469 [TBL] [Abstract][Full Text] [Related]
34. 1H-cyclopentapyrimidine-2,4(1H,3H)-dione-related ionotropic glutamate receptors ligands. structure-activity relationships and identification of potent and Selective iGluR5 modulators. Butini S; Pickering DS; Morelli E; Coccone SS; Trotta F; De Angelis M; Guarino E; Fiorini I; Campiani G; Novellino E; Schousboe A; Christensen JK; Gemma S J Med Chem; 2008 Oct; 51(20):6614-8. PubMed ID: 18811139 [TBL] [Abstract][Full Text] [Related]
35. On the binding determinants of the glutamate agonist with the glutamate receptor ligand binding domain. Speranskiy K; Kurnikova M Biochemistry; 2005 Aug; 44(34):11508-17. PubMed ID: 16114887 [TBL] [Abstract][Full Text] [Related]